Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Long-term prognostic impact of atrial fibrillation subtypes in unselected patients undergoing coronary angiography. Local targets link to admitted publications; unresolved targets remain external evidence.
Atrial fibrillation: a review.
10.1001/jama.2024.22451 · 2025 · External reference
2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
10.1161/cir.0000000000001193 · 2024 · External reference
Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes.
10.1161/circresaha.117.309732 · 2017 · External reference
Modifiable risk factors and atrial fibrillation.
10.1161/circulationaha.116.023163 · 2017 · External reference
Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography.
10.1371/journal.pone.0024964 · 2011 · External reference
Prognostic value of subclinical coronary artery disease in atrial fibrillation patients identified by coronary computed tomography angiography.
10.1016/j.amjcard.2020.03.050 · 2020 · External reference
Atrial fibrillation incidence, prevalence, predictors, and adverse outcomes in acute coronary syndromes: a pooled analysis of data from 8 million patients.
10.1111/jce.15351 · 2022 · External reference
Outcomes of patients with atrial fibrillation undergoing percutaneous coronary intervention.
10.1016/j.jacc.2016.05.085 · 2016 · External reference
Long-term risk of adverse outcomes according to atrial fibrillation type.
10.1038/s41598-022-05688-9 · 2022 · External reference
Type of atrial fibrillation and outcomes in patients with heart failure and reduced ejection fraction.
10.1016/j.jacc.2017.09.027 · 2017 · External reference
Heart failure with preserved ejection fraction and atrial fibrillation: recent advances and open questions.
10.1186/s12916-023-02764-3 · 2023 · External reference
Prognosis and treatment strategies for atrial fibrillation in heart failure with mildly reduced ejection fraction.
10.1093/eurjpc/zwae185 · 2024 · External reference
Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry.
10.1093/eurheartj/ehy626 · 2018 · External reference
Characterizing atrial fibrillation in patients with and without heart failure across the ejection fraction spectrum: Incidence, prevalence, and treatment strategies.
10.1002/ejhf.3402 · 2025 · External reference
2023 ESC Guidelines for the management of acute coronary syndromes.
10.1093/eurheartj/ehad191 · 2023 · External reference
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.
10.1093/eurheartj/ehaa612 · 2021 · External reference
Trends in atrial fibrillation in patients hospitalized with an acute coronary syndrome.
10.1016/j.amjmed.2012.05.024 · 2012 · External reference
Managing atrial fibrillation in patients with heart failure and reduced ejection fraction: a scientific statement from the American Heart Association.
10.1161/hae.0000000000000078 · 2021 · External reference
Early rhythm control therapy in patients with atrial fibrillation and heart failure.
10.1161/circulationaha.121.056323 · 2021 · External reference
Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model.
10.1016/j.ahj.2022.03.009 · 2022 · External reference
Heart failure risk assessment using biomarkers in patients with atrial fibrillation: analysis from COMBINE-AF.
10.1016/j.jacc.2024.07.023 · 2024 · External reference
Application of biomarkers for risk stratification in patients with atrial fibrillation.
10.1373/clinchem.2016.255182 · 2017 · External reference
Atrial fibrillation and atrial cardiomyopathies.
10.1111/jce.15083 · 2021 · External reference
Atrial cardiomyopathy: a useful notion in cardiac disease management or a passing fad?
10.1016/j.jacc.2017.06.033 · 2017 · External reference
Atrial cardiomyopathy in atrial fibrillation: mechanistic pathways and emerging treatment concepts.
10.3390/jcm14093250 · 2025 · External reference
Atrial fibrillation, progression of coronary atherosclerosis and myocardial infarction.
10.1177/2047487316679265 · 2017 · External reference
Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: a systematic review and meta-analysis.
10.1177/2047487317715769 · 2017 · External reference
Prioritising the primary prevention of heart failure.
10.1016/s0140-6736(25)01393-5 · 2025 · External reference